Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Oct 05, 2023 12:29pm
102 Views
Post# 35671290

A subtle change in wording from most recent PR...

A subtle change in wording from most recent PR... If there's anything bad about this company then please let us all know as well because my skin in the game for now at least, is 1.5 million shares with the option to acquire more this December should the price still be lagging reality because the only bad thing I can think of is that the company has not yet turned EPS positive but I really don't consider that a risk but merely just timing and that timing is fast approaching....strong cash position, very little debt, excellent cost controls and management being 'open minded' to "other" deals or the subtle change in wording now from Pidduck, no longer open to M&A activity but rather....

and to thoughtfully consider approaches to the many available consolidation opportunities in the industry.

 I could easily interpret his subtly changed wording as there are many suitors willing to hook up with LABS especially now using the wording of consolidation instead of M&A activity.   And as far as "many available"....Pidduck must have taken a count of those opportunites to say many are available.   

That is your tip off folks, buy the sh*t out of it. 
<< Previous
Bullboard Posts
Next >>